Stan Lipkowitz

3.7k total citations · 2 hit papers
29 papers, 3.0k citations indexed

About

Stan Lipkowitz is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Stan Lipkowitz has authored 29 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 15 papers in Oncology and 9 papers in Cancer Research. Recurrent topics in Stan Lipkowitz's work include Cell death mechanisms and regulation (6 papers), Ubiquitin and proteasome pathways (6 papers) and NF-κB Signaling Pathways (6 papers). Stan Lipkowitz is often cited by papers focused on Cell death mechanisms and regulation (6 papers), Ubiquitin and proteasome pathways (6 papers) and NF-κB Signaling Pathways (6 papers). Stan Lipkowitz collaborates with scholars based in United States, Canada and Chile. Stan Lipkowitz's co-authors include Seth A. Ettenberg, Marion M. Nau, Maccon Keane, Mauricio Cuello, Josef Penninger, E K Russell, Phillip A. Dennis, Connie M. Krawczyk, Amy S. Clark and Jae Young So and has published in prestigious journals such as Nature, Journal of Biological Chemistry and Journal of Clinical Oncology.

In The Last Decade

Stan Lipkowitz

29 papers receiving 3.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Negative regulation of lymphocyte activation and autoimmunity by the molecular adaptor Cbl-b

2000 553 citations Kurt Bachmaier, Connie M. Krawczyk et al. Nature profile →
Triple negative breast cancer (TNBC): Non-genetic tumor heterogeneity and immune microenvironment: Emerging treatment options

2022 143 citations Jae Young So, Joyce E. Ohm et al. Pharmacology & Therapeutics profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Stan Lipkowitz United States	23	1.9k	1.2k	978	432	235	29	3.0k
Marialuisa Sensi Italy	27	1.4k 0.7×	1.1k 0.9×	1.8k 1.9×	287 0.7×	186 0.8×	92	2.9k
Hasan Rajabi United States	39	2.4k 1.3×	1.1k 0.9×	720 0.7×	749 1.7×	369 1.6×	67	3.2k
Malin Pedersen United Kingdom	22	1.3k 0.7×	1.1k 0.9×	673 0.7×	293 0.7×	126 0.5×	37	2.4k
Marion Dorsch United States	32	2.2k 1.2×	1.2k 1.0×	889 0.9×	591 1.4×	83 0.4×	55	3.7k
Mary L. Bath Australia	22	2.0k 1.1×	1.2k 1.0×	1.3k 1.3×	339 0.8×	153 0.7×	30	3.5k
Els M.E. Verdegaal Netherlands	24	1.1k 0.6×	1.6k 1.3×	1.6k 1.6×	373 0.9×	156 0.7×	62	3.1k
Simone Difilippantonio United States	25	2.5k 1.4×	1.2k 1.0×	955 1.0×	644 1.5×	129 0.5×	46	3.6k
Kin-Ming Lo United States	27	1.8k 1.0×	1.4k 1.1×	1.1k 1.1×	688 1.6×	789 3.4×	43	3.5k
Seth A. Ettenberg United States	23	2.8k 1.5×	1.9k 1.6×	1.0k 1.1×	544 1.3×	604 2.6×	44	4.2k
Viia Valge-Archer United Kingdom	19	1.1k 0.6×	1.0k 0.8×	1.2k 1.2×	373 0.9×	238 1.0×	27	2.4k

Countries citing papers authored by Stan Lipkowitz

Since Specialization

Citations

This map shows the geographic impact of Stan Lipkowitz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stan Lipkowitz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stan Lipkowitz more than expected).

Fields of papers citing papers by Stan Lipkowitz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stan Lipkowitz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stan Lipkowitz. The network helps show where Stan Lipkowitz may publish in the future.

Co-authorship network of co-authors of Stan Lipkowitz

This figure shows the co-authorship network connecting the top 25 collaborators of Stan Lipkowitz. A scholar is included among the top collaborators of Stan Lipkowitz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stan Lipkowitz. Stan Lipkowitz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

So, Jae Young, Joyce E. Ohm, Stan Lipkowitz, & Yang Li. (2022). Triple negative breast cancer (TNBC): Non-genetic tumor heterogeneity and immune microenvironment: Emerging treatment options. Pharmacology & Therapeutics. 237. 108253–108253. 143 indexed citations breakdown →

Gatti‐Mays, Margaret E., Claudia Palena, Sofia R. Gameiro, et al.. (2020). Abstract OT1-08-01: A phase Ib trial of sequential combinations of BN-brachyury, entinostat, ado-trastuzumab emtansine (T-DM1) and bintrafusp alfa (M7824) in advanced stage breast cancer (BrEAsT). Cancer Research. 80(4_Supplement). OT1–8. 3 indexed citations

Tice, David A., et al.. (2016). Abstract P5-03-06: MEDI3039, a novel highly potent tumor necrosis factor (TNF)-related apoptosis inducing ligand (TRAIL) receptor agonist, induces apoptotic cell death in breast cancer cells. Cancer Research. 76(4_Supplement). P5–3. 3 indexed citations

Voeller, Donna, Monzur Rahman, Stan Lipkowitz, et al.. (2004). Thymidylate synthase as an oncogene. Cancer Cell. 5(4). 341–351. 149 indexed citations

Peschard, Pascal, Noboru Ishiyama, Lin Tong, Stan Lipkowitz, & Morag Park. (2004). A Conserved DpYR Motif in the Juxtamembrane Domain of the Met Receptor Family Forms an Atypical c-Cbl/Cbl-b Tyrosine Kinase Binding Domain Binding Site Required for Suppression of Oncogenic Activation. Journal of Biological Chemistry. 279(28). 29565–29571. 96 indexed citations

Tan, Antoinette R., Xiaowei Yang, Stephen M. Hewitt, et al.. (2004). Evaluation of Biologic End Points and Pharmacokinetics in Patients With Metastatic Breast Cancer After Treatment With Erlotinib, an Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor. Journal of Clinical Oncology. 22(15). 3080–3090. 149 indexed citations

Davies, Gareth, et al.. (2004). Cbl-b interacts with ubiquitinated proteins; differential functions of the UBA domains of c-Cbl and Cbl-b. Oncogene. 23(42). 7104–7115. 71 indexed citations

Zeng, Shan, Zhiheng Xu, Stan Lipkowitz, & Jack Longley. (2004). Regulation of stem cell factor receptor signaling by Cbl family proteins (Cbl-b/c-Cbl). Blood. 105(1). 226–232. 89 indexed citations

Magnifico, Alessandra, Seth A. Ettenberg, Cuihong Yang, et al.. (2003). WW Domain HECT E3s Target Cbl RING Finger E3s for Proteasomal Degradation. Journal of Biological Chemistry. 278(44). 43169–43177. 144 indexed citations

10.

Nau, Marion M. & Stan Lipkowitz. (2003). Comparative genomic organization of the cbl genes. Gene. 308. 103–113. 39 indexed citations

11.

Lipkowitz, Stan. (2002). The role of the ubiquitination-proteasome pathway in breast cancer: Ubiquitin mediated degradation of growth factor receptors in the pathogenesis and treatment of cancer. Breast Cancer Research. 5(1). 8–15. 45 indexed citations

12.

Cuello, Mauricio, Seth A. Ettenberg, Amy S. Clark, et al.. (2001). Down-regulation of the erbB-2 receptor by trastuzumab (herceptin) enhances tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis in breast and ovarian cancer cell lines that overexpress erbB-2.. PubMed. 61(12). 4892–900. 301 indexed citations

13.

Ettenberg, Seth A., Alessandra Magnifico, Mauricio Cuello, et al.. (2001). Cbl-b-dependent Coordinated Degradation of the Epidermal Growth Factor Receptor Signaling Complex. Journal of Biological Chemistry. 276(29). 27677–27684. 125 indexed citations

14.

Cuello, Mauricio, Seth A. Ettenberg, Marion M. Nau, & Stan Lipkowitz. (2001). Synergistic Induction of Apoptosis by the Combination of TRAIL and Chemotherapy in Chemoresistant Ovarian Cancer Cells. Gynecologic Oncology. 81(3). 380–390. 136 indexed citations

15.

Bachmaier, Kurt, Connie M. Krawczyk, I. Kozieradzki, et al.. (2000). Negative regulation of lymphocyte activation and autoimmunity by the molecular adaptor Cbl-b. Nature. 403(6766). 211–216. 553 indexed citations breakdown →

16.

Keane, Maccon, Yaffa Rubinstein, Mauricio Cuello, et al.. (2000). Inhibition of NF-κB Activity Enhances TRAIL Mediated Apoptosis in Breast Cancer Cell Lines. Breast Cancer Research and Treatment. 64(2). 211–219. 87 indexed citations

17.

Ettenberg, Seth A., Maccon Keane, Marion M. Nau, et al.. (1999). cbl-b inhibits epidermal growth factor receptor signaling. Oncogene. 18(10). 1855–1866. 103 indexed citations

18.

Keane, Maccon, Seth A. Ettenberg, Marion M. Nau, et al.. (1999). cbl-3: a new mammalian cbl family protein. Oncogene. 18(22). 3365–3375. 96 indexed citations

19.

Chen, Wei-Dong, Gregory A. Otterson, Stan Lipkowitz, et al.. (1997). Apoptosis is associated with cleavage of a 5 kDa fragment from RB which mimics dephosphorylation and modulates E2F binding. Oncogene. 14(10). 1243–1248. 69 indexed citations

20.

Keane, Maccon, et al.. (1996). The protein tyrosine phosphatase DEP-1 is induced during differentiation and inhibits growth of breast cancer cells.. PubMed. 56(18). 4236–43. 115 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact